SE429405B - Sett att framstella influensavaccin innhallande aterforenade, seruminhibitorresistenta virusstammar - Google Patents

Sett att framstella influensavaccin innhallande aterforenade, seruminhibitorresistenta virusstammar

Info

Publication number: SE429405B
Authority: SE; Sweden
Prior art keywords: strain; serum; virus; eggs; influenza virus
Prior art date: 1973-09-27

Application number

SE7412113A

Other languages

English (en)

Swedish (sv)

Other versions

SE7412113L (de

Inventor

J Peetermans

Original Assignee

Reccherche Et Ind Therapeutiqu

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1973-09-27

Filing date

1974-09-26

Publication date

1983-09-05

1974-09-26 Application filed by Reccherche Et Ind Therapeutiqu filed Critical Reccherche Et Ind Therapeutiqu

1975-04-01 Publication of SE7412113L publication Critical patent/SE7412113L/xx

1983-09-05 Publication of SE429405B publication Critical patent/SE429405B/sv

Links

210000002966 serum Anatomy 0.000 title claims description 52
241000700605 Viruses Species 0.000 title claims description 34
239000003112 inhibitor Substances 0.000 title claims description 26
239000000126 substance Substances 0.000 title 1
241000712461 unidentified influenza virus Species 0.000 claims description 27
235000013601 eggs Nutrition 0.000 claims description 24
238000010790 dilution Methods 0.000 claims description 19
239000012895 dilution Substances 0.000 claims description 19
241000700199 Cavia porcellus Species 0.000 claims description 9
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 9
238000000034 method Methods 0.000 claims description 9
239000000463 material Substances 0.000 claims description 8
241000287828 Gallus gallus Species 0.000 claims description 6
238000004519 manufacturing process Methods 0.000 claims description 6
230000003612 virological effect Effects 0.000 claims description 6
230000002238 attenuated effect Effects 0.000 claims description 5
206010022000 influenza Diseases 0.000 claims description 3
229940124873 Influenza virus vaccine Drugs 0.000 claims description 2
241000282339 Mustela Species 0.000 description 14
229960005486 vaccine Drugs 0.000 description 13
241000283073 Equus caballus Species 0.000 description 8
230000035931 haemagglutination Effects 0.000 description 6
238000011081 inoculation Methods 0.000 description 6
239000000203 mixture Substances 0.000 description 6
241001465754 Metazoa Species 0.000 description 5
239000001888 Peptone Substances 0.000 description 5
108010080698 Peptones Proteins 0.000 description 5
239000012530 fluid Substances 0.000 description 5
235000019319 peptone Nutrition 0.000 description 5
230000000694 effects Effects 0.000 description 3
239000011521 glass Substances 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
239000002054 inoculum Substances 0.000 description 3
230000001717 pathogenic effect Effects 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000012360 testing method Methods 0.000 description 3
241000283690 Bos taurus Species 0.000 description 2
241000282412 Homo Species 0.000 description 2
230000008859 change Effects 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
229940099472 immunoglobulin a Drugs 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000036512 infertility Effects 0.000 description 2
229960003971 influenza vaccine Drugs 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
239000000243 solution Substances 0.000 description 2
238000002255 vaccination Methods 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
206010019233 Headaches Diseases 0.000 description 1
206010028735 Nasal congestion Diseases 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
238000010171 animal model Methods 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
238000009835 boiling Methods 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
244000309464 bull Species 0.000 description 1
244000309466 calf Species 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
238000002955 isolation Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
229940037525 nasal preparations Drugs 0.000 description 1
210000001989 nasopharynx Anatomy 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000009467 reduction Effects 0.000 description 1
208000023504 respiratory system disease Diseases 0.000 description 1
230000004044 response Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
206010039083 rhinitis Diseases 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
238000007086 side reaction Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Virology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pulmonology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

SE7412113A 1973-09-27 1974-09-26 Sett att framstella influensavaccin innhallande aterforenade, seruminhibitorresistenta virusstammar SE429405B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US05/401,335 US3953592A (en)	1973-09-27	1973-09-27	Live influenza virus vaccines and preparation thereof

Publications (2)

Publication Number	Publication Date
SE7412113L SE7412113L (de)	1975-04-01
SE429405B true SE429405B (sv)	1983-09-05

Family

ID=23587327

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7412113A SE429405B (sv)	1973-09-27	1974-09-26	Sett att framstella influensavaccin innhallande aterforenade, seruminhibitorresistenta virusstammar

Country Status (22)

Country	Link
US (1)	US3953592A (de)
JP (1)	JPS5058223A (de)
AT (1)	AT331978B (de)
BE (1)	BE819865A (de)
CA (1)	CA1030450A (de)
CH (1)	CH595447A5 (de)
CS (1)	CS203080B2 (de)
DD (1)	DD114966A5 (de)
DE (1)	DE2445819A1 (de)
DK (1)	DK508274A (de)
ES (1)	ES430415A1 (de)
FI (1)	FI278774A (de)
FR (1)	FR2245376B1 (de)
GB (1)	GB1461188A (de)
HU (1)	HU169383B (de)
IE (1)	IE40180B1 (de)
IL (1)	IL45589A (de)
LU (1)	LU70998A1 (de)
NL (1)	NL7411746A (de)
NO (1)	NO743433L (de)
SE (1)	SE429405B (de)
ZA (1)	ZA745571B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6042209B2 (ja) *	1974-05-31	1985-09-20	北里研究所（社団法人）	インフルエンザウイルスの新鮮分離株を発育鶏卵へ短期間で順化させる方法
US4318903A (en) *	1978-07-12	1982-03-09	Smithkline-Rit	Live influenza virus vaccine and the preparation thereof
US4278662A (en) *	1979-10-16	1981-07-14	Smith Kline - Rit	Attenuated influenza type A virus vaccine
JPS59163313A (ja) *	1983-03-09	1984-09-14	Teijin Ltd	経鼻投与用ペプチドホルモン類組成物
US4783411A (en) *	1984-10-22	1988-11-08	Janis Gabliks	Influenza-A virus vaccine from fish cell cultures
NZ224422A (en) *	1987-05-05	1990-11-27	Molecular Eng Ass	Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US7678087B2 (en) *	1999-09-29	2010-03-16	Heska Corporation	Equine intranasal delivery system
US6398774B1 (en)	1999-09-29	2002-06-04	Heska Corporation	Intranasal delivery system
EP2411049B1 (de)	2009-03-27	2020-01-15	Academia Sinica	Verfahren und zusammensetzungen zur immunisierung gegen viren
TWI537385B (zh)	2010-11-04	2016-06-11	中央研究院	產生具簡單醣基化之表面蛋白質之病毒顆粒的方法

1973
- 1973-09-27 US US05/401,335 patent/US3953592A/en not_active Expired - Lifetime
1974
- 1974-08-28 CH CH1173374A patent/CH595447A5/xx not_active IP Right Cessation
- 1974-08-29 CA CA208,125A patent/CA1030450A/en not_active Expired
- 1974-08-30 ZA ZA00745571A patent/ZA745571B/xx unknown
- 1974-09-04 IL IL45589A patent/IL45589A/en unknown
- 1974-09-04 NL NL7411746A patent/NL7411746A/xx not_active Application Discontinuation
- 1974-09-13 FR FR7431029A patent/FR2245376B1/fr not_active Expired
- 1974-09-13 BE BE148474A patent/BE819865A/xx not_active IP Right Cessation
- 1974-09-21 JP JP49109440A patent/JPS5058223A/ja active Pending
- 1974-09-24 CS CS746552A patent/CS203080B2/cs unknown
- 1974-09-24 NO NO743433A patent/NO743433L/no unknown
- 1974-09-25 DE DE19742445819 patent/DE2445819A1/de not_active Ceased
- 1974-09-25 FI FI2787/74A patent/FI278774A/fi unknown
- 1974-09-25 LU LU70998A patent/LU70998A1/xx unknown
- 1974-09-26 SE SE7412113A patent/SE429405B/sv unknown
- 1974-09-26 HU HURE565A patent/HU169383B/hu unknown
- 1974-09-26 IE IE1994/74A patent/IE40180B1/xx unknown
- 1974-09-26 AT AT776074A patent/AT331978B/de active
- 1974-09-26 GB GB4184974A patent/GB1461188A/en not_active Expired
- 1974-09-26 ES ES430415A patent/ES430415A1/es not_active Expired
- 1974-09-26 DK DK508274A patent/DK508274A/da unknown
- 1974-09-26 DD DD181344A patent/DD114966A5/xx unknown

Also Published As

Publication number	Publication date
CS203080B2 (en)	1981-02-27
NO743433L (de)	1975-04-28
LU70998A1 (de)	1975-03-06
SE7412113L (de)	1975-04-01
ATA776074A (de)	1975-12-15
IE40180L (en)	1975-03-27
FR2245376B1 (de)	1978-07-28
DD114966A5 (de)	1975-09-05
ES430415A1 (es)	1977-02-01
CA1030450A (en)	1978-05-02
US3953592A (en)	1976-04-27
GB1461188A (en)	1977-01-13
HU169383B (de)	1976-11-28
DE2445819A1 (de)	1975-04-10
DK508274A (de)	1975-06-02
AU7330674A (en)	1976-03-18
IL45589A (en)	1977-05-31
ZA745571B (en)	1975-09-24
IE40180B1 (en)	1979-03-28
BE819865A (fr)	1975-03-13
AT331978B (de)	1976-09-10
FI278774A (de)	1975-03-28
FR2245376A1 (de)	1975-04-25
CH595447A5 (de)	1978-02-15
NL7411746A (nl)	1975-04-02
IL45589A0 (en)	1974-11-29
JPS5058223A (de)	1975-05-21

Publication	Publication Date	Title
US4693893A (en)	1987-09-15	Vaccines for equine influenza
Simpson et al.	1961	Genetic recombination among influenza viruses: I. Cross reactivation of plaque-forming capacity as a method for selecting recombinants from the progeny of crosses between influenza A strains
Takada et al.	1999	Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic
Virelizier	1975	Host defenses against influenza virus: the role of anti-hemagglutinin antibody
US5762939A (en)	1998-06-09	Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
EP0891420B1 (de)	2005-02-02	Verfahren fuer die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren
US5597721A (en)	1997-01-28	Preparation of antigens of and of vaccines for the virus of mystery disease, antigens and vaccines obtained for the prevention of this disease
US4338296A (en)	1982-07-06	Influenza virus and process of producing a vaccine therefrom
KR20090088944A (ko)	2009-08-20	배양물 속에서 인플루엔자 바이러스를 복제하는 방법
EP0279563B1 (de)	1994-04-20	Influenza-Impfstoff
SE429405B (sv)	1983-09-05	Sett att framstella influensavaccin innhallande aterforenade, seruminhibitorresistenta virusstammar
JP2014511119A (ja)	2014-05-08	Ｈ１ｎ１亜型インフルエンザパンデミックウイルスに対する新型ワクチン
Hooks et al.	1972	Characterization and distribution of two new foamy viruses isolated from chimpanzees
RU2757723C2 (ru)	2021-10-21	Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита
AU2002253542B2 (en)	2007-06-07	Purified subfragment encoding neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
Kono et al.	1980	An epidemic of Getah virus infection among racehorses: properties of the virus
Della-Porta et al.	2018	Bovine ephemeral fever virus
CA1152895A (en)	1983-08-30	Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them
Van Kirk et al.	1971	Evaluation of low temperature grown influenza A2/Hong Kong virus in volunteers
CS199569B2 (en)	1980-07-31	Method of producing vaccine against influenza
Scott et al.	1970	Respiratory syncytial virus neutralizing activity in nasopharyngeal secretions
CN107384875A (zh)	2017-11-24	克服雏鸡新城疫母源抗体影响的嵌合新城疫病毒载体h7活疫苗候选株及其构建方法
EP0105364B1 (de)	1990-03-28	Temperaturempfindliche reassortierende viren und impfstoff gegen pferdeinfluenza
Kilbourne et al.	1979	Hemagglutinin mutants of swine influenza virus differing in replication characteristics in their natural host
KR101627623B1 (ko)	2016-06-08	이종 인플루엔자 바이러스에 대한 백신 조성물